N. Willmott
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Advanced Drug Delivery Systems 10
- Oncology 20
- Cancer Treatment and Pharmacology 10
- Co-authors
- Jeffrey L. Cummings (15 shared papers)Alastair J. Florence (8 shared papers)John F. Smyth (7 shared papers)CS McArdle (12 shared papers)DJ Kerr (8 shared papers)Alan Rogerson (1 shared paper)J. H. McKillop (8 shared papers)Lorraine Anderson (1 shared paper)
- Journals
- British Journal of Cancer (9 papers)Biochemical Pharmacology (7 papers)Journal of Pharmacy and Pharmacology (4 papers)Journal of Controlled Release (3 papers)Nuclear Medicine Communications (3 papers)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
N. Willmott
65 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 327
- Hepatology 138
- Biomaterials 237
- Oncology 386
- Toxicology 51
Countries citing papers authored by N. Willmott
This map shows the geographic impact of N. Willmott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Willmott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Willmott more than expected).
Fields of papers citing papers by N. Willmott
This network shows the impact of papers produced by N. Willmott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Willmott. The network helps show where N. Willmott may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Willmott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 148 | |
| 2 | 1991 | 136 | |
| 3 | 1985 | 97 | |
| 4 | 1987 | 69 | |
| 5 | 1988 | 65 | |
| 6 | 1997 | 57 | |
| 7 | 1986 | 44 | |
| 8 | 1992 | 41 | |
| 9 | 1991 | 39 | |
| 10 | 1992 | 38 | |
| 11 | 1989 | 38 | |
| 12 | 1992 | 37 | |
| 13 | 1987 | 33 | |
| 14 | 1988 | 32 | |
| 15 | 1991 | 30 | |
| 16 | 1996 | 29 | |
| 17 | 1988 | 27 | |
| 18 | 1985 | 25 | |
| 19 | 2008 | 25 | |
| 20 | 1987 | 22 |
About N. Willmott
N. Willmott is a scholar working on Pharmaceutical Science, Oncology, Hepatology, Biomaterials and Biotechnology, having authored 67 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Nanoparticle-Based Drug Delivery (10 papers), Advanced Drug Delivery Systems (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Research and Treatments (6 papers), Protein Interaction Studies and Fluorescence Analysis (6 papers) and Lanthanide and Transition Metal Complexes (6 papers). The work is most often cited by research in Pharmaceutical Science (327 citations), Hepatology (138 citations), Biomaterials (237 citations), Oncology (386 citations) and Toxicology (51 citations). N. Willmott has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Jeffrey L. Cummings, Alastair J. Florence, John F. Smyth, CS McArdle, DJ Kerr, Alan Rogerson, J. H. McKillop, Lorraine Anderson, Joseph C. Anderson and Yan Chen. Their work appears in journals such as British Journal of Cancer, Biochemical Pharmacology, Journal of Pharmacy and Pharmacology, Journal of Controlled Release and Nuclear Medicine Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.